Space stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

In the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...

For the last five years, the theme on the street has mostly been: Buy today, expect comfort tomorrow. But some of the better wealth-creatin...

RPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Max Healthcare has significantly increased its bed capacity to 6,500 with a new Saket facility. This expansion targets both domestic patien...

The funds will be used for expanding operations, opening new centres, and diversifying the range of services offered, said the Mumbai-based...

Beta Drugs is well placed to capitalise on the growth opportunities in the oncology drugs segment, aided by its comprehensive product portf...

The company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...

Bugworks Research said it will continue to invest in its proprietary drug discovery platforms GYROX (for AMR) and DARE (for Immuno-oncology...

The company has built world-class facilities in terms of processes etc. No short cuts here.

The startup utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumor and modulate the tumor immun...

Glenmark announced the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a state...

Drug firm Strides Arcolab on Tuesday said its subsidiary has received approval from the US health regulator for the launch of Gemcitabine i...

Mid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina.

It is raining deals at Bangalore-based mid-sized pharma player Strides Arcolab.